Cramb G, Dow J W
Biochem Pharmacol. 1983 Jan 15;32(2):227-31. doi: 10.1016/0006-2952(83)90548-8.
Isolated rat ventricular myocytes accumulate large amounts of bepridil intracellularly. The mode of transport is uncertain but uptake is of such a magnitude as to mask possible sarcolemmal binding sites. Bepridil is tightly bound within myocytes, there being only a minimal efflux into bepridil-free medium. Purified F-actin binds bepridil in excess of 2 moles/mole actin, sufficient to account for the uptake of bepridil by myocytes incubated in 10 microM drug. At higher bepridil concentrations the amount transported into myocytes suggests that the drug may be distributed between actin-bound and cytoplasmic pools. Bepridil may alter cardiac contractility by a direct influence on the contractile filaments.
分离的大鼠心室肌细胞在细胞内积累大量的苄普地尔。转运方式尚不确定,但摄取量很大,以至于可能掩盖了肌膜结合位点。苄普地尔在肌细胞内紧密结合,仅有极少部分外流到不含苄普地尔的培养基中。纯化的F-肌动蛋白结合苄普地尔的量超过2摩尔/摩尔肌动蛋白,这足以解释在10微摩尔药物中孵育的肌细胞对苄普地尔的摄取。在更高的苄普地尔浓度下,转运到肌细胞内的药物量表明该药物可能分布在肌动蛋白结合池和细胞质池中。苄普地尔可能通过直接影响收缩细丝来改变心脏收缩力。